While orforglipron succeeded in a Phase 3 trial, its weight loss effects were more modest than investors and analysts ...

The FDA had halted use in older adults while it investigated reports of side effects. The vaccine’s label now carries new ...

The fundraise will help advance a cancer therapy that’s already shown early promise in people whose cancers haven’t responded ...

A spokesperson confirmed the company plans to reduce its workforce by “less than 20%,” months after significantly lowering ...

The initiative is a response to a Trump administration order to speed the construction of the type of new drug factories many pharmaceutical companies have promised to build.